IOVANCE BIOTHERAPEUTICS, INC. financial data

Symbol
IOVA on Nasdaq
Location
San Carlos, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 364% % -12%
Quick Ratio 44% % 88%
Debt-to-equity 28% % -1.1%
Return On Equity -55% % 5.5%
Return On Assets -43% % 5.2%
Operating Margin -166% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 396,967,970 shares 30%
Common Stock, Shares, Outstanding 385,461,728 shares 27%
Entity Public Float $2,100,000,000 USD 50%
Common Stock, Value, Issued $16,000 USD 23%
Weighted Average Number of Shares Outstanding, Basic 364,037 shares 20%
Weighted Average Number of Shares Outstanding, Diluted 334,511 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $250,425,000 USD 15%
Cost of Revenue $198,730,000 USD 22%
Research and Development Expense $304,849,000 USD 2.9%
General and Administrative Expense $158,899,000 USD 13%
Costs and Expenses $666,897,000 USD 28%
Operating Income (Loss) $416,472,000 USD 3.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $398,330,000 USD 4.3%
Income Tax Expense (Benefit) $697,000 USD 89%
Net Income (Loss) Attributable to Parent $397,633,000 USD 3%
Earnings Per Share, Basic -1 USD/shares 21%
Earnings Per Share, Diluted -1 USD/shares 28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $158,134,000 USD -3.7%
Accounts Receivable, after Allowance for Credit Loss, Current $66,761,000 USD 20%
Inventory, Net $51,710,000 USD 34%
Assets, Current $429,091,000 USD -14%
Property, Plant and Equipment, Net $126,650,000 USD 13%
Operating Lease, Right-of-Use Asset $48,763,000 USD -27%
Other Assets, Noncurrent $9,271,000 USD 3211%
Assets $904,948,000 USD -8.7%
Accounts Payable, Current $31,237,000 USD -1.4%
Accrued Liabilities, Current $87,267,000 USD 17%
Liabilities, Current $125,785,000 USD 6.5%
Deferred Income Tax Liabilities, Net $31,665,000 USD -1.7%
Operating Lease, Liability, Noncurrent $45,211,000 USD -32%
Liabilities $202,661,000 USD -6.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $16,103,000 USD -0.86%
Retained Earnings (Accumulated Deficit) $2,703,626,000 USD -17%
Stockholders' Equity Attributable to Parent $702,287,000 USD -9.2%
Liabilities and Equity $904,948,000 USD -8.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $103,694,000 USD 15%
Net Cash Provided by (Used in) Financing Activities $143,315,000 USD -26%
Net Cash Provided by (Used in) Investing Activities $15,867,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 385,461,728 shares 27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $55,996,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $164,099,000 USD -3.8%
Deferred Tax Assets, Valuation Allowance $557,587,000 USD 25%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $574,517,000 USD 24%
Operating Lease, Liability $51,492,000 USD -34%
Payments to Acquire Property, Plant, and Equipment $6,211,000 USD 49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $397,772,000 USD -3.4%
Lessee, Operating Lease, Liability, to be Paid $84,852,000 USD -31%
Property, Plant and Equipment, Gross $171,974,000 USD 15%
Operating Lease, Liability, Current $6,281,000 USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,469,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,509,000 USD -56%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $1,838,000 USD -31%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33,360,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,016,000 USD -39%
Deferred Tax Assets, Operating Loss Carryforwards $302,875,000 USD 18%
Unrecognized Tax Benefits $29,854,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,838,000 USD -42%
Operating Lease, Payments $16,289,000 USD -5.6%
Additional Paid in Capital $3,389,792,000 USD 11%
Amortization of Intangible Assets $22,475,000 USD 15%
Depreciation, Depletion and Amortization $12,178,000 USD 2.5%
Deferred Tax Assets, Net of Valuation Allowance $16,930,000 USD -4%